Merger proposal

Gracell Biotechnologies announced Tuesday that its shareholders approved the company’s sale to AstraZeneca at an extraordinary general meeting on Feb. 19.

FAST NEWS: Gracell shareholders approve merger with AstraZeneca

The latest: Gracell Biotechnologies Inc. (GRCL.US) announced Tuesday that its shareholders approved the company’s sale to AstraZeneca (AZN.L) at an extraordinary general meeting on Feb. 19. Looking up: Gracell’s merger with…
GRCL.US

Recent Articles

RELATED ARTICLES

  1. AstraZnenca tax probe
    AstraZeneca could face limited fallout from Chinese tax probe
    AZN.US
  2. NEWS WRAP: AstraZeneca China president assisting in investigation
    AZN.US
  3. Jinko sees sunnier skies in Germany with new fundraising plan
    JKS.US 688223.SHG
  4. ZG Group set to forge Hong Kong’s second De-SPAC listing
    2572.HK
  5. Seyond may get stuck in slow-moving SPAC lane to Hong Kong listing
    7855.HK
  6. BRIEF: Synagistics completes Hong Kong’s first listing via SPAC merger
    2562.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva